Want to join the conversation?
$M's comparable sales on an owned plus licensed basis for 4Q15 were down 4.3%. On an owned basis, comparable sales declined by 4.8%. Operating income was $936MM or 10.6% of sales for 4Q15, down from $1.36Bil or 14.6% of sales in the previous year quarter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.